
    
      Subjects who meet all inclusion/exclusion criteria and sign the informed consent/assent were
      enrolled. Subjects were randomized to receive solithromycin or a comparator antibiotic,
      administered IV and/or by mouth (PO) based on weight and age. Subjects were treated daily for
      5 to 7 days with oral solithromycin and 5 to 7 days with IV or IV-to-oral solithromycin.
      Subjects were treated for 5 to 10 days with comparator antibiotics. Subjects received safety
      and efficacy assessments during and after treatment.
    
  